Delivery Order SPE2DB20D1109-SPE2DB23FN74M
Award Date 3/17/23
Potential Completion Date 3/20/23
Potential Value $2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,120.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order for the pharmaceutical product Emgality 120 mg/ml, a medication used for the treatment of migraines. The contract has a firm fixed price pricing type and an ultimate completion date of August 31, 2021. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,935.07, is for the delivery of Emgality 120 mg/ml pen medication. It is a Firm Fixed Price Delivery Order contract with a completion date of February 12, 2024. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Emgality 120 mg/ml injectable medication. The contract, valued at $1,151.82, is a firm fixed-price delivery order that runs through November 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management (SAM.gov). This contract award is not designated...
- This federal contract award is for the delivery of the pharmaceutical product Emgality 120 mg/ml penml to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $1,884.63, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,074.80 contract is for the supply of Emgality 120 mg/mL pens, a medication used to treat migraines. The award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $1,064.77, is for the delivery of the pharmaceutical product Emgality 120 mg/ml pen by December 29, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through November 2026. This IDC serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,642.29 firm-fixed-price delivery order is for the supply of Emgality 120 mg/ml pen-injectors, a prescription medication used for the treatment of migraine. The award has an ultimate completion date of November 13, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
- This federal contract award is a $3,102.57 delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the pharmaceutical product Emgality 300 mg (100 mg x 3 syringes) and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award, valued at $1,002.72, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the pharmaceutical product Emgality 120 mg/mL pen, with a performance period through April 12, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor on an indefinite delivery contract (IDC) with DLA,...
- This is a $3,008.16 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Emgality 120 mg/ml pen injectors, a medication used to treat migraine. The award has a period of performance through September 12, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...